|29.22||-1.26 / -4.13%|
As of 3:59pm ET
|29.12||-0.10 / -0.34%|
The 6 analysts offering 12-month price forecasts for Horizon Pharma PLC have a median target of 42.00, with a high estimate of 51.00 and a low estimate of 40.00. The median estimate represents a +43.74% increase from the last price of 29.22.
The current consensus among 6 polled investment analysts is to Buy stock in Horizon Pharma PLC. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.